Nancy R. Gough 
In August, CDC updated testing guidance regarding COVID-19. The subsequent news reporting resulted in confusion. A few points of clarification: People who have recovered from COVID-19 should not consider themselves no risk to themselves or others. They should still practice social distancing and wear a mask or face covering when in close proximity to people … Read more
Valneva reports the subjects in Phase II clinical trial of Lyme disease vaccine develop antibodies. The results were positive enough to inspire Pfizer to join with Valneva to continue testing in the next phase of clinical trials and, hopefully, bring this to market. Find out more about the vaccine strategy and Lyme disease: Read More … Read more
Researchers in academia and biotech firms are working to develop devices that can detect if a person has COVID-19 by analyzing their breath. Respiratory infections, like the one caused by the SARS-COV-2 virus and influenza viruses, cause changes in our metabolism. These changes result in volatile organic chemicals, which are present in exhaled breath. Several … Read more
Researchers discover loss-of-function mutations in TLR7 as a genetic basis for severe COVID-19.
Often clinical researchers will use data from medical records to try to uncover clues to treatment effectiveness. This is exactly what a group in Michigan did. They took medical records from hospitalized COVID-19 patients and used statistical approaches to evaluate if patients receiving hydroxychloroquine fared better or worse than patients who did not. Although this … Read more